Sandoz Gets US Denosumab Approvals – But When Will They Launch?

FDA Also Grants Interchangeability Designation For First Biosimilars To Prolia And Xgeva

 
• By David Wallace
  
Two Blue And Black Badges Representing FDA Approvals
Sandoz has received two denosumab biosimilar approvals • Source: Shutterstock

More from Biosimilars

More from Products